Provided by Tiger Trade Technology Pte. Ltd.

Redhill Biopharma

0.6964
+0.04647.14%
Pre-market: 0.6801-0.0163-2.34%07:36 EDT
Volume:231.76K
Turnover:155.67K
Market Cap:4.23M
PE:-5.13
High:0.7097
Open:0.6500
Low:0.6500
Close:0.6500
52wk High:2.79
52wk Low:0.5700
Shares:6.08M
Float Shares:5.02M
Volume Ratio:0.17
T/O Rate:4.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1358
EPS(LYR):-0.1358
ROE:-1708.61%
ROA:-22.79%
PB:0.99
PE(LYR):-5.13

Loading ...

RedHill announces acquisition of commercialization rights to Rebyota, Clenpiq

TIPRANKS
·
Sep 01

Press Release: RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota(R) and Clenpiq(R)

Dow Jones
·
Sep 01

NASDAQ Trade Halt Volatility Trading Pause at 09:36 Am

Reuters
·
Aug 31

RedHill Biopharma Sells Talicia Stake to Apotex for $18 Million Upfront

Reuters
·
Aug 31

Press Release: RedHill Divests Talicia(R) to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities

Dow Jones
·
Aug 31

NASDAQ Trade Halt Halt News Pending at 06:57 Am

Reuters
·
Aug 31

RedHill Biopharma Releases Corporate Presentation Outlining Talicia Commercialization, Late-stage Pipeline Progress

Reuters
·
Aug 03

Redhill Biopharma Delays Annual Shareholder Meeting to Aug. 6 to Add Proposal to Proxy Materials

Reuters
·
Jul 01

Redhill Biopharma Ups Maximum Size of H.C. Wainwright-led ATM ADS Offering

Reuters
·
Jun 29

RedHill Biopharma Closes Private Placement

MT Newswires Live
·
Jun 23

RedHill Biopharma prices $6 million private placement of ADSs at $0.7 each

Reuters
·
Jun 23

RedHill Biopharma prices $6 million private placement at $0.70 per ADS

Reuters
·
Jun 18

Press Release: RedHill Biopharma Announces Up To $19.4 Million Private Placement

Dow Jones
·
Jun 18

RedHill (RDHL) Gains FDA Rare Pediatric Disease Designation, Opening Door to Potential Priority Review Voucher (PRV) Upside

TIPRANKS
·
Jun 16

RedHill Biopharma posts corporate presentation on Talicia commercialization and GI-focused pipeline

Reuters
·
Jun 15

RedHill Biopharma’s Opaganib Ebola Plan Gives RDHL Stock a New Catalyst

TIPRANKS
·
Jun 10

RedHill Biopharma's Opaganib Gains FDA Rare Pediatric Disease Status for Neuroblastoma

MT Newswires Live
·
Jun 09

RedHill says FDA grants opaganib rare pediatric disease designation for neuroblastoma

Reuters
·
Jun 09

RedHill Biopharma launches enforcement of $11M judgment against Kukbo

TIPRANKS
·
Jun 08

Redhill Biopharma Advances Opaganib Options For Ebola Virus Disease Outbreak

Reuters
·
Jun 04